Navigation Links
Oclaro Provides Complete Fiber Laser Diode Solutions Portfolio; Outlines Future Innovation and Technology Advancements

SAN JOSE, Calif., May 18, 2011 /PRNewswire/ -- Oclaro, Inc. (NASDAQ: OCLR), a tier-one provider of optical communications and laser solutions, today outlined its complete line of fiber laser solutions and disclosed the technology direction of future products.  As a leading provider of diodes for industrial fiber laser solutions, Oclaro is able to leverage its world-class manufacturing operations, technology expertise and packaging technology to consistently deliver industry-leading performance, quality, brightness, and cost competiveness.  The company's full suite of seed and pump lasers will be on display at next week's LASER World of PHOTONICS show in Munich in the Oclaro booth #469, Hall C1 in the New Munich Trade Fair Centre.

Fiber lasers have been steadily gaining market share from conventional non-fiber laser solutions in the industrial market because they deliver excellent performance and reliability at a more efficient cost point, in particular for micro and high power materials processing.  Because fiber lasers are based on fiber optics (no moving parts), they tend to be more cost effective (fewer parts, more compact), have longer life expectancy, and deliver high beam quality at similar power levels, which enables them to produce less errors and work faster than non-fiber solutions.  Due to these advantages, the market for fiber laser solutions is expected to grow 15-20 percent per year in an industry estimated at $1.5 billion today.*

"Through our focus on vertical integration, technology leadership and world-class manufacturing operations, Oclaro has the resources and expertise to continually advance fiber laser technology while maintaining industry-leading cost structures," said Jim Haynes, President and General Manager, Photonic Components Business Unit at Oclaro. "Today, we are not only showcasing the complete laser diode solutions we have already brought to market, but we are also putting a stake in the ground to let our customers know that our future products will push the limits on pricing, efficiency, footprint, brightness and reliability."

Oclaro's Current and Future Fiber Laser solutions

Oclaro delivers one of the most complete portfolios of diodes for fiber laser solutions today.  These products include the following:

  • 915 to 976nm BMU single emitters - 10W from a 105um fiber.  90% of the light contained in a 0.12 NA.
  • 915 to 976nm BMU multi-emitter - 25W from a 105um fiber.  90% of the light contained in a 0.12 NA.
  • Orion VBG - 20W from a 105um fiber.  Wavelength locked at 976 nm, <-0.5 nm FWHM.  90% of the light contained in a 0.18 NA.
  • Seed Lasers - High output power, up to 400mW kink free CW or 1.2W pulsed peak at 1060nm, single mode lasers.

For future products, Oclaro intends to leverage its vast technology and manufacturing resources to continue improving the efficiency, beam strength, and reliability of its fiber laser diode offerings.  The company anticipates that future pump lasers will drive pricing to well below $10 per watt, significantly improve efficiency, reduce packaging footprint by 20 percent and increase brightness by 30 percent.   Below is a summary of the types of innovations Oclaro intends to bring to market in the future:

  • Develop higher brightness/power single emitter chips
  • Develop range of MM multi-emitter solutions to address various market segments (low and mid power)
  • Introduce super high power solutions for KW through fiber combining trays
  • Provide improved wavelength stability with gratings
  • Expand single mode seed laser portfolio to include new wavelengths and low-noise options

About Oclaro

Oclaro, Inc. (NASDAQ: OCLR) is a tier-one provider of optical communications and laser components, modules and subsystems for a broad range of diverse markets, including telecommunications, industrial, scientific, consumer electronics, and medical. Oclaro is a global leader, dedicated to photonics innovation with cutting-edge research and development (R&D) and chip fabrication facilities in the U.K., Switzerland and Italy, and in-house and contract manufacturing sites in the U.S., Thailand and China. To support its diverse and global customer base, Oclaro maintains design, sales and service organizations in each of the major regions around the world. For more information visit

Copyright 2011. All rights reserved. Oclaro, the Oclaro logo, and certain other Oclaro trademarks and logos are trademarks and/or registered trademarks of Oclaro, Inc. or its subsidiaries in the US and other countries. All other trademarks are the property of their respective owners. Information in this release is subject to change without notice.

* Projected market data is based on internal Oclaro estimates and information from external analyst reports.

SOURCE Oclaro, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Oclaro Next-Generation Orion Fiber-Coupled Diode Laser Raises the Bar for Performance, Cost and Reliability for Solid State Lasers
2. Access Pharmaceuticals Provides Update on MuGard Commercial Activities
3. Lilly Provides Its Perspective in Response to Amylin Lawsuit
4. Lilly Provides Statement in Response to Amylin Lawsuit
5. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
6. Nutrastar Provides First Quarter 2011 Financial Results Release Date and Conference Call Details
7. Alexza Reports 2011 First Quarter Financial Results and Provides Business Update
8. Robotic Couch Provides Extra Degree of Precision for Patients Undergoing Radiation Therapy for Cancer
9. China Botanic Pharmaceutical Provides Update on Badger Oil Sales
10. Atrium Provides Grant to Establish Education Web Site at
11. Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck
Post Your Comments:
(Date:10/9/2015)... DIEGO , Oct. 9, 2015 Ansun ... (Infectious Disease Society of America ) regarding the compassionate ... transplant patient on a respirator who was co-infected with ... a five-day course of therapy, O 2 requirement ... the patient was able to go off the respirator ...
(Date:10/8/2015)... October 9, 2015 ® ... diagnostic colonoscopy. The NOCT study also assessed the ... --> ® ) in adult patients ... study also assessed the compliance, safety, patient acceptability ... today announced positive top line results for its ...
(Date:10/8/2015)... PITTSBURGH , Oct. 8, 2015 /PRNewswire/ ... pharmaceutical company, will host a conference call and webcast ... ET to review the value to be created for ... TASE) through Mylan,s offer to acquire the company. During ... outlines the compelling proposition for Perrigo shareholders. Mylan,s offer ...
Breaking Medicine Technology:
... IDEV Technologies, Inc. (IDEV) today announced the firm ... Australia,s regulatory agency for medical drugs and devices, for ... and peripheral procedures. "We are pleased to ... SUPERA VERITAS in the Australian market later this year," ...
... 28, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ... evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the ... Paris, France. "The data we are ... an important new treatment option for patients with multiple ...
Cached Medicine Technology:
(Date:10/10/2015)... ... October 10, 2015 , ... Story Chaser is a ... by reading various classics and inspiring stories and as words drop down and users ... animations are extremely aesthetic and can be interacted with, making it a more engaging ...
(Date:10/9/2015)... ... 2015 , ... Doctors on Liens has teamed up with a ... needed medical care to personal injury victims. When personal injury victims suffer major, ... treat the variety of conditions ailing them. With the addition of this new ...
(Date:10/9/2015)... WASHINGTON, NH (PRWEB) , ... October 09, 2015 , ... ... Sore Throat Home Exam Aid, is now available online ( ) – just ... and Prevention (CDC) says officially begins in October. However, for many in the U.S., ...
(Date:10/9/2015)... ... October 09, 2015 , ... Head Over Heels Athletic Arts ... developmental camp at the Karolyi Ranch in Huntsville, Texas on October 17-21. , ... Heels girls team head coach and executive director, said. “It's a stepping stone into ...
(Date:10/9/2015)... ... October 09, 2015 , ... Cambias ... the surrounding communities, is initiating a combined charity effort with Animal Rescue New ... in southern Louisiana. , Animal Rescue New Orleans is a non-profit organization ...
Breaking Medicine News(10 mins):
... Eye Research Institute (SERI) found that increasing the contrast ... enjoyable to the visually impaired. // ,The U.S. ... device to help millions suffering eye diseases. People who ... from macular degeneration, diabetic retinopathy and other causes of ...
... family and community medicine and colleagues developed the latest tool ... developed a tool which is called the Newest vital sign. ... based on an ice cream nutrition label. Based on the ... literacy can be calculated. , Then it is ...
... has been legalized in Canada the sex workers feel that the ... public for negotiating with their customers in public and does not ... rented flat.// The sex workers organization feels that the law will ... to brutality and killing, as they are not sure about the ...
... undergo a liver transplant at the St James's University Hospital in ... to take as long as 10 hours, in which half the ... ,Lennox developed chronic liver problems and jaundice within weeks after his ... a transplant appeared to be the only way of saving his ...
... San Diego have designed mice containing fully functional human nerve ... neurodegenerative diseases such as Parkinson's and Alzheimer's. // ... the neurons were formed in the brains of mice that ... embryos. ,Studies showed that the human stem ...
... The human brain can be manipulated to get relief from ... University in California. ,As many as eight patients were ... brains while performing // mental exercises. Standard therapy has ... possibilities can be opened through the results of the research. ...
Cached Medicine News:
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: